P. Paul et al., HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression, HUMAN IMMUN, 61(11), 2000, pp. 1177-1195
Non-classical MHC class I HLA-E, -F, and -G molecules differ from classical
class I histocompatibility antigens by specific patterns of transcription,
protein expression, and immunological functions. Restriction of the expres
sion pattern of these non-classical antigens may play a key role in modulat
ion of immune responses during pregnancy and diseases but remains to be add
itionally defined. A specific component of the second International Confere
nce on HLA-G and the 13th HLA-G Histocompatibility Workshop will be dedicat
ed to the analysis of transcription and expression of non-classical class I
genes in normal and pathological tissues. In a first step, referred to as
the preworkshop, we here report the analysis and conclusions of a working g
roup which was constituted to gather and validate optimal reagents and prot
ocols allowing RT-PCR analysis of HLA-E, -F, -G transcript levels and flow
cytometry and immunochemistry analysis of HLA-G expression in cells and tis
sues. As a result of this work, use of specific primers and probes detectin
g alternative transcripts of HLA-E, -F, and G have been validated in transf
ected cells expressing differential pattern of HLA class I antigens, Analys
is of the specificity and affinity of collected antibodies has allowed defi
nition of reagents to be proposed for immunochemistry and flow cytometry an
alysis of HLA-G expression in normal and pathological tissues during the wo
rkshop. This work has allowed constitution of an extended workshop group wh
ich is now initiating analysis of non-classical class I transcription and e
xpression in various cells and tissues, a collective contribution that will
additionally refine our view of the expression of these antigens in normal
and pathological situations. (C) American Society for Histocompatibility a
nd Immunogenetics, 2000. Published by Elsevier Science Inc.